Sen. Suzy Glowiak Hilton

Filed: 5/9/2023

 

 


 

 


 
10300HB3428sam001LRB103 29807 RJT 61200 a

1
AMENDMENT TO HOUSE BILL 3428

2    AMENDMENT NO. ______. Amend House Bill 3428 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The School Code is amended by changing Section
522-30 as follows:
 
6    (105 ILCS 5/22-30)
7    Sec. 22-30. Self-administration and self-carry of asthma
8medication and epinephrine injectors; administration of
9undesignated epinephrine injectors; administration of an
10opioid antagonist; administration of undesignated asthma
11medication; asthma episode emergency response protocol.
12    (a) For the purpose of this Section only, the following
13terms shall have the meanings set forth below:
14    "Asthma action plan" means a written plan developed with a
15pupil's medical provider to help control the pupil's asthma.
16The goal of an asthma action plan is to reduce or prevent

 

 

10300HB3428sam001- 2 -LRB103 29807 RJT 61200 a

1flare-ups and emergency department visits through day-to-day
2management and to serve as a student-specific document to be
3referenced in the event of an asthma episode.
4    "Asthma episode emergency response protocol" means a
5procedure to provide assistance to a pupil experiencing
6symptoms of wheezing, coughing, shortness of breath, chest
7tightness, or breathing difficulty.
8    "Epinephrine injector" includes an auto-injector approved
9by the United States Food and Drug Administration for the
10administration of epinephrine and a pre-filled syringe
11approved by the United States Food and Drug Administration and
12used for the administration of epinephrine that contains a
13pre-measured dose of epinephrine that is equivalent to the
14dosages used in an auto-injector.
15    "Asthma medication" means quick-relief asthma medication,
16including albuterol or other short-acting bronchodilators,
17that is approved by the United States Food and Drug
18Administration for the treatment of respiratory distress.
19"Asthma medication" includes medication delivered through a
20device, including a metered dose inhaler with a reusable or
21disposable spacer or a nebulizer with a mouthpiece or mask.
22    "Opioid antagonist" means a drug that binds to opioid
23receptors and blocks or inhibits the effect of opioids acting
24on those receptors, including, but not limited to, naloxone
25hydrochloride or any other similarly acting drug approved by
26the U.S. Food and Drug Administration.

 

 

10300HB3428sam001- 3 -LRB103 29807 RJT 61200 a

1    "Respiratory distress" means the perceived or actual
2presence of wheezing, coughing, shortness of breath, chest
3tightness, breathing difficulty, or any other symptoms
4consistent with asthma. Respiratory distress may be
5categorized as "mild-to-moderate" or "severe".
6    "School nurse" means a registered nurse working in a
7school with or without licensure endorsed in school nursing.
8    "Self-administration" means a pupil's discretionary use of
9his or her prescribed asthma medication or epinephrine
10injector.
11    "Self-carry" means a pupil's ability to carry his or her
12prescribed asthma medication or epinephrine injector.
13    "Standing protocol" may be issued by (i) a physician
14licensed to practice medicine in all its branches, (ii) a
15licensed physician assistant with prescriptive authority, or
16(iii) a licensed advanced practice registered nurse with
17prescriptive authority.
18    "Trained personnel" means any school employee or volunteer
19personnel authorized in Sections 10-22.34, 10-22.34a, and
2010-22.34b of this Code who has completed training under
21subsection (g) of this Section to recognize and respond to
22anaphylaxis, an opioid overdose, or respiratory distress.
23    "Undesignated asthma medication" means asthma medication
24prescribed in the name of a school district, public school,
25charter school, or nonpublic school.
26    "Undesignated epinephrine injector" means an epinephrine

 

 

10300HB3428sam001- 4 -LRB103 29807 RJT 61200 a

1injector prescribed in the name of a school district, public
2school, charter school, or nonpublic school.
3    (b) A school, whether public, charter, or nonpublic, must
4permit the self-administration and self-carry of asthma
5medication by a pupil with asthma or the self-administration
6and self-carry of an epinephrine injector by a pupil, provided
7that:
8        (1) the parents or guardians of the pupil provide to
9    the school (i) written authorization from the parents or
10    guardians for (A) the self-administration and self-carry
11    of asthma medication or (B) the self-carry of asthma
12    medication or (ii) for (A) the self-administration and
13    self-carry of an epinephrine injector or (B) the
14    self-carry of an epinephrine injector, written
15    authorization from the pupil's physician, physician
16    assistant, or advanced practice registered nurse; and
17        (2) the parents or guardians of the pupil provide to
18    the school (i) the prescription label, which must contain
19    the name of the asthma medication, the prescribed dosage,
20    and the time at which or circumstances under which the
21    asthma medication is to be administered, or (ii) for the
22    self-administration or self-carry of an epinephrine
23    injector, a written statement from the pupil's physician,
24    physician assistant, or advanced practice registered nurse
25    containing the following information:
26            (A) the name and purpose of the epinephrine

 

 

10300HB3428sam001- 5 -LRB103 29807 RJT 61200 a

1        injector;
2            (B) the prescribed dosage; and
3            (C) the time or times at which or the special
4        circumstances under which the epinephrine injector is
5        to be administered.
6The information provided shall be kept on file in the office of
7the school nurse or, in the absence of a school nurse, the
8school's administrator.
9    (b-5) A school district, public school, charter school, or
10nonpublic school may authorize the provision of a
11student-specific or undesignated epinephrine injector to a
12student or any personnel authorized under a student's
13Individual Health Care Action Plan, Illinois Food Allergy
14Emergency Action Plan and Treatment Authorization Form, or
15plan pursuant to Section 504 of the federal Rehabilitation Act
16of 1973 to administer an epinephrine injector to the student,
17that meets the student's prescription on file.
18    (b-10) The school district, public school, charter school,
19or nonpublic school may authorize a school nurse or trained
20personnel to do the following: (i) provide an undesignated
21epinephrine injector to a student for self-administration only
22or any personnel authorized under a student's Individual
23Health Care Action Plan, Illinois Food Allergy Emergency
24Action Plan and Treatment Authorization Form, plan pursuant to
25Section 504 of the federal Rehabilitation Act of 1973, or
26individualized education program plan to administer to the

 

 

10300HB3428sam001- 6 -LRB103 29807 RJT 61200 a

1student that meets the student's prescription on file; (ii)
2administer an undesignated epinephrine injector that meets the
3prescription on file to any student who has an Individual
4Health Care Action Plan, Illinois Food Allergy Emergency
5Action Plan and Treatment Authorization Form, plan pursuant to
6Section 504 of the federal Rehabilitation Act of 1973, or
7individualized education program plan that authorizes the use
8of an epinephrine injector; (iii) administer an undesignated
9epinephrine injector to any person that the school nurse or
10trained personnel in good faith believes is having an
11anaphylactic reaction; (iv) administer an opioid antagonist to
12any person that the school nurse or trained personnel in good
13faith believes is having an opioid overdose; (v) provide
14undesignated asthma medication to a student for
15self-administration only or to any personnel authorized under
16a student's Individual Health Care Action Plan or asthma
17action plan, plan pursuant to Section 504 of the federal
18Rehabilitation Act of 1973, or individualized education
19program plan to administer to the student that meets the
20student's prescription on file; (vi) administer undesignated
21asthma medication that meets the prescription on file to any
22student who has an Individual Health Care Action Plan or
23asthma action plan, plan pursuant to Section 504 of the
24federal Rehabilitation Act of 1973, or individualized
25education program plan that authorizes the use of asthma
26medication; and (vii) administer undesignated asthma

 

 

10300HB3428sam001- 7 -LRB103 29807 RJT 61200 a

1medication to any person that the school nurse or trained
2personnel believes in good faith is having respiratory
3distress.
4    (c) The school district, public school, charter school, or
5nonpublic school must inform the parents or guardians of the
6pupil, in writing, that the school district, public school,
7charter school, or nonpublic school and its employees and
8agents, including a physician, physician assistant, or
9advanced practice registered nurse providing standing protocol
10and a prescription for school epinephrine injectors, an opioid
11antagonist, or undesignated asthma medication, are to incur no
12liability or professional discipline, except for willful and
13wanton conduct, as a result of any injury arising from the
14administration of asthma medication, an epinephrine injector,
15or an opioid antagonist regardless of whether authorization
16was given by the pupil's parents or guardians or by the pupil's
17physician, physician assistant, or advanced practice
18registered nurse. The parents or guardians of the pupil must
19sign a statement acknowledging that the school district,
20public school, charter school, or nonpublic school and its
21employees and agents are to incur no liability, except for
22willful and wanton conduct, as a result of any injury arising
23from the administration of asthma medication, an epinephrine
24injector, or an opioid antagonist regardless of whether
25authorization was given by the pupil's parents or guardians or
26by the pupil's physician, physician assistant, or advanced

 

 

10300HB3428sam001- 8 -LRB103 29807 RJT 61200 a

1practice registered nurse and that the parents or guardians
2must indemnify and hold harmless the school district, public
3school, charter school, or nonpublic school and its employees
4and agents against any claims, except a claim based on willful
5and wanton conduct, arising out of the administration of
6asthma medication, an epinephrine injector, or an opioid
7antagonist regardless of whether authorization was given by
8the pupil's parents or guardians or by the pupil's physician,
9physician assistant, or advanced practice registered nurse.
10    (c-5) When a school nurse or trained personnel administers
11an undesignated epinephrine injector to a person whom the
12school nurse or trained personnel in good faith believes is
13having an anaphylactic reaction, administers an opioid
14antagonist to a person whom the school nurse or trained
15personnel in good faith believes is having an opioid overdose,
16or administers undesignated asthma medication to a person whom
17the school nurse or trained personnel in good faith believes
18is having respiratory distress, notwithstanding the lack of
19notice to the parents or guardians of the pupil or the absence
20of the parents or guardians signed statement acknowledging no
21liability, except for willful and wanton conduct, the school
22district, public school, charter school, or nonpublic school
23and its employees and agents, and a physician, a physician
24assistant, or an advanced practice registered nurse providing
25standing protocol and a prescription for undesignated
26epinephrine injectors, an opioid antagonist, or undesignated

 

 

10300HB3428sam001- 9 -LRB103 29807 RJT 61200 a

1asthma medication, are to incur no liability or professional
2discipline, except for willful and wanton conduct, as a result
3of any injury arising from the use of an undesignated
4epinephrine injector, the use of an opioid antagonist, or the
5use of undesignated asthma medication, regardless of whether
6authorization was given by the pupil's parents or guardians or
7by the pupil's physician, physician assistant, or advanced
8practice registered nurse.
9    (d) The permission for self-administration and self-carry
10of asthma medication or the self-administration and self-carry
11of an epinephrine injector is effective for the school year
12for which it is granted and shall be renewed each subsequent
13school year upon fulfillment of the requirements of this
14Section.
15    (e) Provided that the requirements of this Section are
16fulfilled, a pupil with asthma may self-administer and
17self-carry his or her asthma medication or a pupil may
18self-administer and self-carry an epinephrine injector (i)
19while in school, (ii) while at a school-sponsored activity,
20(iii) while under the supervision of school personnel, or (iv)
21before or after normal school activities, such as while in
22before-school or after-school care on school-operated property
23or while being transported on a school bus.
24    (e-5) Provided that the requirements of this Section are
25fulfilled, a school nurse or trained personnel may administer
26an undesignated epinephrine injector to any person whom the

 

 

10300HB3428sam001- 10 -LRB103 29807 RJT 61200 a

1school nurse or trained personnel in good faith believes to be
2having an anaphylactic reaction (i) while in school, (ii)
3while at a school-sponsored activity, (iii) while under the
4supervision of school personnel, or (iv) before or after
5normal school activities, such as while in before-school or
6after-school care on school-operated property or while being
7transported on a school bus. A school nurse or trained
8personnel may carry undesignated epinephrine injectors on his
9or her person while in school or at a school-sponsored
10activity.
11    (e-10) Provided that the requirements of this Section are
12fulfilled, a school nurse or trained personnel may administer
13an opioid antagonist to any person whom the school nurse or
14trained personnel in good faith believes to be having an
15opioid overdose (i) while in school, (ii) while at a
16school-sponsored activity, (iii) while under the supervision
17of school personnel, or (iv) before or after normal school
18activities, such as while in before-school or after-school
19care on school-operated property. A school nurse or trained
20personnel may carry an opioid antagonist on his or her person
21while in school or at a school-sponsored activity.
22    (e-15) If the requirements of this Section are met, a
23school nurse or trained personnel may administer undesignated
24asthma medication to any person whom the school nurse or
25trained personnel in good faith believes to be experiencing
26respiratory distress (i) while in school, (ii) while at a

 

 

10300HB3428sam001- 11 -LRB103 29807 RJT 61200 a

1school-sponsored activity, (iii) while under the supervision
2of school personnel, or (iv) before or after normal school
3activities, including before-school or after-school care on
4school-operated property. A school nurse or trained personnel
5may carry undesignated asthma medication on his or her person
6while in school or at a school-sponsored activity.
7    (f) The school district, public school, charter school, or
8nonpublic school may maintain a supply of undesignated
9epinephrine injectors in any secure location that is
10accessible before, during, and after school where an allergic
11person is most at risk, including, but not limited to,
12classrooms and lunchrooms. A physician, a physician assistant
13who has prescriptive authority in accordance with Section 7.5
14of the Physician Assistant Practice Act of 1987, or an
15advanced practice registered nurse who has prescriptive
16authority in accordance with Section 65-40 of the Nurse
17Practice Act may prescribe undesignated epinephrine injectors
18in the name of the school district, public school, charter
19school, or nonpublic school to be maintained for use when
20necessary. Any supply of epinephrine injectors shall be
21maintained in accordance with the manufacturer's instructions.
22    The school district, public school, charter school, or
23nonpublic school shall may maintain a supply of an opioid
24antagonist in any secure location where an individual may have
25an opioid overdose, unless there is a shortage of opioid
26antagonists, in which case the school district, public school,

 

 

10300HB3428sam001- 12 -LRB103 29807 RJT 61200 a

1charter school, or nonpublic school shall make a reasonable
2effort to maintain a supply of an opioid antagonist. Unless
3the school district, public school, charter school, or
4nonpublic school is able to obtain opioid antagonists without
5a prescription, a A health care professional who has been
6delegated prescriptive authority for opioid antagonists in
7accordance with Section 5-23 of the Substance Use Disorder Act
8shall may prescribe opioid antagonists in the name of the
9school district, public school, charter school, or nonpublic
10school, to be maintained for use when necessary. Any supply of
11opioid antagonists shall be maintained in accordance with the
12manufacturer's instructions.
13    The school district, public school, charter school, or
14nonpublic school may maintain a supply of asthma medication in
15any secure location that is accessible before, during, or
16after school where a person is most at risk, including, but not
17limited to, a classroom or the nurse's office. A physician, a
18physician assistant who has prescriptive authority under
19Section 7.5 of the Physician Assistant Practice Act of 1987,
20or an advanced practice registered nurse who has prescriptive
21authority under Section 65-40 of the Nurse Practice Act may
22prescribe undesignated asthma medication in the name of the
23school district, public school, charter school, or nonpublic
24school to be maintained for use when necessary. Any supply of
25undesignated asthma medication must be maintained in
26accordance with the manufacturer's instructions.

 

 

10300HB3428sam001- 13 -LRB103 29807 RJT 61200 a

1    (f-3) Whichever entity initiates the process of obtaining
2undesignated epinephrine injectors and providing training to
3personnel for carrying and administering undesignated
4epinephrine injectors shall pay for the costs of the
5undesignated epinephrine injectors.
6    (f-5) Upon any administration of an epinephrine injector,
7a school district, public school, charter school, or nonpublic
8school must immediately activate the EMS system and notify the
9student's parent, guardian, or emergency contact, if known.
10    Upon any administration of an opioid antagonist, a school
11district, public school, charter school, or nonpublic school
12must immediately activate the EMS system and notify the
13student's parent, guardian, or emergency contact, if known.
14    (f-10) Within 24 hours of the administration of an
15undesignated epinephrine injector, a school district, public
16school, charter school, or nonpublic school must notify the
17physician, physician assistant, or advanced practice
18registered nurse who provided the standing protocol and a
19prescription for the undesignated epinephrine injector of its
20use.
21    Within 24 hours after the administration of an opioid
22antagonist, a school district, public school, charter school,
23or nonpublic school must notify the health care professional
24who provided the prescription for the opioid antagonist of its
25use.
26    Within 24 hours after the administration of undesignated

 

 

10300HB3428sam001- 14 -LRB103 29807 RJT 61200 a

1asthma medication, a school district, public school, charter
2school, or nonpublic school must notify the student's parent
3or guardian or emergency contact, if known, and the physician,
4physician assistant, or advanced practice registered nurse who
5provided the standing protocol and a prescription for the
6undesignated asthma medication of its use. The district or
7school must follow up with the school nurse, if available, and
8may, with the consent of the child's parent or guardian,
9notify the child's health care provider of record, as
10determined under this Section, of its use.
11    (g) Prior to the administration of an undesignated
12epinephrine injector, trained personnel must submit to the
13school's administration proof of completion of a training
14curriculum to recognize and respond to anaphylaxis that meets
15the requirements of subsection (h) of this Section. Training
16must be completed annually. The school district, public
17school, charter school, or nonpublic school must maintain
18records related to the training curriculum and trained
19personnel.
20    Prior to the administration of an opioid antagonist,
21trained personnel must submit to the school's administration
22proof of completion of a training curriculum to recognize and
23respond to an opioid overdose, which curriculum must meet the
24requirements of subsection (h-5) of this Section. Training
25must be completed annually. Trained personnel must also submit
26to the school's administration proof of cardiopulmonary

 

 

10300HB3428sam001- 15 -LRB103 29807 RJT 61200 a

1resuscitation and automated external defibrillator
2certification. The school district, public school, charter
3school, or nonpublic school must maintain records relating to
4the training curriculum and the trained personnel.
5    Prior to the administration of undesignated asthma
6medication, trained personnel must submit to the school's
7administration proof of completion of a training curriculum to
8recognize and respond to respiratory distress, which must meet
9the requirements of subsection (h-10) of this Section.
10Training must be completed annually, and the school district,
11public school, charter school, or nonpublic school must
12maintain records relating to the training curriculum and the
13trained personnel.
14    (h) A training curriculum to recognize and respond to
15anaphylaxis, including the administration of an undesignated
16epinephrine injector, may be conducted online or in person.
17    Training shall include, but is not limited to:
18        (1) how to recognize signs and symptoms of an allergic
19    reaction, including anaphylaxis;
20        (2) how to administer an epinephrine injector; and
21        (3) a test demonstrating competency of the knowledge
22    required to recognize anaphylaxis and administer an
23    epinephrine injector.
24    Training may also include, but is not limited to:
25        (A) a review of high-risk areas within a school and
26    its related facilities;

 

 

10300HB3428sam001- 16 -LRB103 29807 RJT 61200 a

1        (B) steps to take to prevent exposure to allergens;
2        (C) emergency follow-up procedures, including the
3    importance of calling 9-1-1 or, if 9-1-1 is not available,
4    other local emergency medical services;
5        (D) how to respond to a student with a known allergy,
6    as well as a student with a previously unknown allergy;
7        (E) other criteria as determined in rules adopted
8    pursuant to this Section; and
9        (F) any policy developed by the State Board of
10    Education under Section 2-3.190.
11    In consultation with statewide professional organizations
12representing physicians licensed to practice medicine in all
13of its branches, registered nurses, and school nurses, the
14State Board of Education shall make available resource
15materials consistent with criteria in this subsection (h) for
16educating trained personnel to recognize and respond to
17anaphylaxis. The State Board may take into consideration the
18curriculum on this subject developed by other states, as well
19as any other curricular materials suggested by medical experts
20and other groups that work on life-threatening allergy issues.
21The State Board is not required to create new resource
22materials. The State Board shall make these resource materials
23available on its Internet website.
24    (h-5) A training curriculum to recognize and respond to an
25opioid overdose, including the administration of an opioid
26antagonist, may be conducted online or in person. The training

 

 

10300HB3428sam001- 17 -LRB103 29807 RJT 61200 a

1must comply with any training requirements under Section 5-23
2of the Substance Use Disorder Act and the corresponding rules.
3It must include, but is not limited to:
4        (1) how to recognize symptoms of an opioid overdose;
5        (2) information on drug overdose prevention and
6    recognition;
7        (3) how to perform rescue breathing and resuscitation;
8        (4) how to respond to an emergency involving an opioid
9    overdose;
10        (5) opioid antagonist dosage and administration;
11        (6) the importance of calling 9-1-1 or, if 9-1-1 is
12    not available, other local emergency medical services;
13        (7) care for the overdose victim after administration
14    of the overdose antagonist;
15        (8) a test demonstrating competency of the knowledge
16    required to recognize an opioid overdose and administer a
17    dose of an opioid antagonist; and
18        (9) other criteria as determined in rules adopted
19    pursuant to this Section.
20    (h-10) A training curriculum to recognize and respond to
21respiratory distress, including the administration of
22undesignated asthma medication, may be conducted online or in
23person. The training must include, but is not limited to:
24        (1) how to recognize symptoms of respiratory distress
25    and how to distinguish respiratory distress from
26    anaphylaxis;

 

 

10300HB3428sam001- 18 -LRB103 29807 RJT 61200 a

1        (2) how to respond to an emergency involving
2    respiratory distress;
3        (3) asthma medication dosage and administration;
4        (4) the importance of calling 9-1-1 or, if 9-1-1 is
5    not available, other local emergency medical services;
6        (5) a test demonstrating competency of the knowledge
7    required to recognize respiratory distress and administer
8    asthma medication; and
9        (6) other criteria as determined in rules adopted
10    under this Section.
11    (i) Within 3 days after the administration of an
12undesignated epinephrine injector by a school nurse, trained
13personnel, or a student at a school or school-sponsored
14activity, the school must report to the State Board of
15Education in a form and manner prescribed by the State Board
16the following information:
17        (1) age and type of person receiving epinephrine
18    (student, staff, visitor);
19        (2) any previously known diagnosis of a severe
20    allergy;
21        (3) trigger that precipitated allergic episode;
22        (4) location where symptoms developed;
23        (5) number of doses administered;
24        (6) type of person administering epinephrine (school
25    nurse, trained personnel, student); and
26        (7) any other information required by the State Board.

 

 

10300HB3428sam001- 19 -LRB103 29807 RJT 61200 a

1    If a school district, public school, charter school, or
2nonpublic school maintains or has an independent contractor
3providing transportation to students who maintains a supply of
4undesignated epinephrine injectors, then the school district,
5public school, charter school, or nonpublic school must report
6that information to the State Board of Education upon adoption
7or change of the policy of the school district, public school,
8charter school, nonpublic school, or independent contractor,
9in a manner as prescribed by the State Board. The report must
10include the number of undesignated epinephrine injectors in
11supply.
12    (i-5) Within 3 days after the administration of an opioid
13antagonist by a school nurse or trained personnel, the school
14must report to the State Board of Education, in a form and
15manner prescribed by the State Board, the following
16information:
17        (1) the age and type of person receiving the opioid
18    antagonist (student, staff, or visitor);
19        (2) the location where symptoms developed;
20        (3) the type of person administering the opioid
21    antagonist (school nurse or trained personnel); and
22        (4) any other information required by the State Board.
23    (i-10) Within 3 days after the administration of
24undesignated asthma medication by a school nurse, trained
25personnel, or a student at a school or school-sponsored
26activity, the school must report to the State Board of

 

 

10300HB3428sam001- 20 -LRB103 29807 RJT 61200 a

1Education, on a form and in a manner prescribed by the State
2Board of Education, the following information:
3        (1) the age and type of person receiving the asthma
4    medication (student, staff, or visitor);
5        (2) any previously known diagnosis of asthma for the
6    person;
7        (3) the trigger that precipitated respiratory
8    distress, if identifiable;
9        (4) the location of where the symptoms developed;
10        (5) the number of doses administered;
11        (6) the type of person administering the asthma
12    medication (school nurse, trained personnel, or student);
13        (7) the outcome of the asthma medication
14    administration; and
15        (8) any other information required by the State Board.
16    (j) By October 1, 2015 and every year thereafter, the
17State Board of Education shall submit a report to the General
18Assembly identifying the frequency and circumstances of
19undesignated epinephrine and undesignated asthma medication
20administration during the preceding academic year. Beginning
21with the 2017 report, the report shall also contain
22information on which school districts, public schools, charter
23schools, and nonpublic schools maintain or have independent
24contractors providing transportation to students who maintain
25a supply of undesignated epinephrine injectors. This report
26shall be published on the State Board's Internet website on

 

 

10300HB3428sam001- 21 -LRB103 29807 RJT 61200 a

1the date the report is delivered to the General Assembly.
2    (j-5) Annually, each school district, public school,
3charter school, or nonpublic school shall request an asthma
4action plan from the parents or guardians of a pupil with
5asthma. If provided, the asthma action plan must be kept on
6file in the office of the school nurse or, in the absence of a
7school nurse, the school administrator. Copies of the asthma
8action plan may be distributed to appropriate school staff who
9interact with the pupil on a regular basis, and, if
10applicable, may be attached to the pupil's federal Section 504
11plan or individualized education program plan.
12    (j-10) To assist schools with emergency response
13procedures for asthma, the State Board of Education, in
14consultation with statewide professional organizations with
15expertise in asthma management and a statewide organization
16representing school administrators, shall develop a model
17asthma episode emergency response protocol before September 1,
182016. Each school district, charter school, and nonpublic
19school shall adopt an asthma episode emergency response
20protocol before January 1, 2017 that includes all of the
21components of the State Board's model protocol.
22    (j-15) Every 2 years, school personnel who work with
23pupils shall complete an in-person or online training program
24on the management of asthma, the prevention of asthma
25symptoms, and emergency response in the school setting. In
26consultation with statewide professional organizations with

 

 

10300HB3428sam001- 22 -LRB103 29807 RJT 61200 a

1expertise in asthma management, the State Board of Education
2shall make available resource materials for educating school
3personnel about asthma and emergency response in the school
4setting.
5    (j-20) On or before October 1, 2016 and every year
6thereafter, the State Board of Education shall submit a report
7to the General Assembly and the Department of Public Health
8identifying the frequency and circumstances of opioid
9antagonist administration during the preceding academic year.
10This report shall be published on the State Board's Internet
11website on the date the report is delivered to the General
12Assembly.
13    (k) The State Board of Education may adopt rules necessary
14to implement this Section.
15    (l) Nothing in this Section shall limit the amount of
16epinephrine injectors that any type of school or student may
17carry or maintain a supply of.
18(Source: P.A. 101-81, eff. 7-12-19; 102-413, eff. 8-20-21;
19102-813, eff. 5-13-22.)".